• Produktbild: Nano-Oncologicals
  • Produktbild: Nano-Oncologicals

Nano-Oncologicals New Targeting and Delivery Approaches

Fr. 192.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

04.11.2014

Abbildungen

XIV, 58 illus., 51 illus. in color., farbige Illustrationen, schwarz-weiss Illustrationen

Herausgeber

Maria José Alonso + weitere

Verlag

Springer

Seitenzahl

473

Maße (L/B/H)

24.1/16/3.2 cm

Gewicht

925 g

Auflage

2014

Sprache

Englisch

ISBN

978-3-319-08083-3

Beschreibung

Portrait

María José Alonso is Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC) in Spain. She has made critical contributions to the design of novel nanostructures for the targeted delivery of drugs and vaccines and to the understanding of the interaction of nanoparticles with biological barriers. She is part of the scientific boards of a number of societies and the executive board of the Controlled Release Society. She is also a member of the editorial board of eight prestigious journals in the field of drug delivery.

Marcos Garcia-Fuentes is an Associate Professor of Pharmacy at Spain’s University of Santiago de Compostela (USC), where he also obtained his Ph.D. He was a visiting scholar at Purdue University in Indiana, USA and a Marie Curie postdoctoral scientist at ETH Zurich in Switzerland. He was recognized with a competitive contract from the regional government for the reintegration of excellent researchers. Marcos has work in the design of biomaterials and nanostructures for medical applications. His current focus is on nanomedicines and biomaterials for modulating progenitor cells and cancer stem cells.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

04.11.2014

Abbildungen

XIV, 58 illus., 51 illus. in color., farbige Illustrationen, schwarz-weiss Illustrationen

Herausgeber

Verlag

Springer

Seitenzahl

473

Maße (L/B/H)

24.1/16/3.2 cm

Gewicht

925 g

Auflage

2014

Sprache

Englisch

ISBN

978-3-319-08083-3

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

Die Leseprobe wird geladen.
  • Produktbild: Nano-Oncologicals
  • Produktbild: Nano-Oncologicals
  • 1: Biological barriers in cancer therapy - Alberto Gabizon, The Hebrew University of Jerusalem, Jerusalem, Israel - Kinam Park, Purdue University, West Lafayette, IN, US   2: Passive vs active targeting, an update of the EPR role - Jean C. Leroux, EHT, Zurich, Switzerland   3: Biomarkers and targeting ligands in cancer nanotherapy - Jessie L.-S. Au, the Ohio State University, US - Louis M. Weiner, Georgetown University Medical Center, Washington DC, US   4: Metal Organic Frameworks for theranostics - Patrick Couvreur, University of Paris Sud, France   5: Micro- bubbles  and theranostics - Joyce Wong, Boston University, USA   6: Iron oxide nanoparticles for theranostics - Twan Lammers, University of Twente, Enschede (NL) - Yuri Volkov, Trinity College Dublin, Dublin (IRL)   7: Multilayer assemblies as carriers for oncologicals - Paula Hammond, MIT, Cambridge, MA, US - Erkki Ruoslahti, Wayne State University, Detroit, MI, US. - Weiyue Lu, School of Pharmacy, Fudan University, Shanghai, China - Yong Zhang, National University of Singapore, Singapore   8: Phototargeted nanoparticles as carriers for oncologicals - Daniel Kohane, Children hospital, Boston, MA, US   9: Targeted liposomes and micelles as carriers for oncologicals - Vladimir Torchilin, Western University, Boston, MA, US - Kazunory Kataoka, The University of Tokyo, Tokyo, Japan   10: Cancer immunomodulation and immunosupressing cells - Enzo Bronte; Istituto Oncologico Veneto (IOV), IRCCS, 35128 Padua, Italy - Alberto Mantovani, University of Milan, Rozzano, Italy - Lisa M. Coussens, University of California, San Francisco, CA, US   11: Polymer-base delivery vehicles for anticancer vaccines - Jeffrey Hubell, EPFL, Lausane, Switzerland - David Mooney, Harvard University, Boston, US   12: Liposomes and immunomodulation - Gert Storm, Utrecht University, Utrecht, The Netherlands - G. Lopez-Berenstein, MD Anderson, Houston, TX, US - Afsaneh Lavasanifar, University of Alberta, Edmonton, Alberta, Canada   13: Novel polymers for RNA delivery - Mark Davis, Caltech, Pasadena, CA, US - Ernest Wagner, Ludwig-Maximilians-Universität, Munich, Germany - Mansoor Amiji, Northeastern University, Boston, MA, US   14: Lipids and lipoids for RNA delivery - L Huang, University of North Carolina, Chapel Hill, NC, US - Dan Anderson, MIT, Cambridge, MA, US   15: Toxicity and regulatory aspects of oncologicals - Ruth Duncan, University of Cardiff, UK - Rogerio Gaspar, University of Lisbon, Portugal - Bengt Fadeel, Karolinska Institute, Sweden   16: Case study: PLA-PEG targeted nanoparticles - Jeff Hrkach, Bind Biosciences, Boston, US   17: Case study: gene therapy using polymer carriers - Marisol Soengas, Bioncotherapies, Valencia, Spain¿